Strides Pharma Q4FY23 sales at Rs 9,904 million cr, up 14%Y-o-Y; loss narrows 133% YoY to Rs 9.54 cr
Mumbai: Strides Pharma’s quarterly sales stood at Rs 9,904 million, growing 14% increase both sequentially and year-on-year.
India’s pharma exports grow by 103 pc since 2013-14
New Delhi: Indian pharma exports witnessed a growth of 103 percent since 2013-14, from Rs 90,415 crores to Rs 1,83,422 crores in 2021-22.
India poised to become 'global hub for medicines': DCGI
New Delhi: There has been a fourfold increase in applications of the investigational new drugs in the country, according to Dr VG Somani, Drug Controller General of India (DCGI), media reports said.
Strides Pharma records 11 pc YoY revenue increase in Q2FY21
Kolkata/IBNS: Strides Pharma Science Ltd (BSE: 532531, NSE: STAR) today announced its consolidated financial results for the quarter (Q2FY21).